| Overview |
| bsm-62715r-rbitc-100ul |
| AER61 Recombinant Antibody, RBITC Conjugated |
| WB |
| Human, Mouse, Rat |
| Specifications |
| RBITC |
| Rabbit |
| KLH conjugated synthetic peptide derived from human EOGT |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 285203 |
| Q5NDL2 |
| Cytoplasm |
| AOS4; C3orf64; EOGT; EOGT1;AER61. |
| Catalyzes the transfer of a single N-acetylglucosamine from UDP-GlcNAc to a serine or threonine residue in extracellular proteins resulting in their modification with a beta-linked N-acetylglucosamine (O-GlcNAc). Specifically glycosylates the Thr residue located between the fifth and sixth conserved cysteines of folded EGF-like domains. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz